Literature DB >> 34842931

The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support.

Delphine Staumont-Sallé, Charles Taieb1, Stephanie Merhand, Jason Shourick.   

Abstract

The evaluation of global atopic dermatitis control is key to minimizing disease burden. The Atopic Dermatitis Control Tool (ADCT) has been developed for this purpose. Participants (diagnosed by a physician) were recruited to this observational cross-sectional study using real-life methodology and completed a questionnaire on sociodemographic and personal information. The ADCT algorithm, described by Pariser, was used to categorize patients as having controlled or uncontrolled atopic dermatitis. Data were collected for 1,606 patients. Median age of the patients was 40 years , and 1,023 (63.7%) patients were women. A total of 1,146 (71.4%) patients had uncontrolled atopic dermatitis according to the ADCT score. Patients with uncontrolled disease were at significantly higher risk of a high stress level and were more likely to be absent from work than those with controlled disease. In conclusion, a key factor for predicting disease burden in atopic dermatitis is patient self-assessed disease control in terms of multiple dimensions: stress, sleep, quality of life, work absenteeism and loss of productivity.

Entities:  

Mesh:

Year:  2021        PMID: 34842931      PMCID: PMC9472094          DOI: 10.2340/actadv.v101.750

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  26 in total

1.  The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective.

Authors:  Carolyn R Charman; Andrea J Venn; Hywel C Williams
Journal:  Arch Dermatol       Date:  2004-12

2.  Analysis of Trends in Geographic Distribution of US Dermatology Workforce Density.

Authors:  Alex M Glazer; Darrell S Rigel
Journal:  JAMA Dermatol       Date:  2017-05-01       Impact factor: 10.282

3.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

Review 4.  Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.

Authors:  Patrick M Brunner; Jonathan I Silverberg; Emma Guttman-Yassky; Amy S Paller; Kenji Kabashima; Masayuki Amagai; Thomas A Luger; Mette Deleuran; Thomas Werfel; Kilian Eyerich; Georg Stingl
Journal:  J Invest Dermatol       Date:  2016-10-20       Impact factor: 8.551

5.  Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment.

Authors:  Lieneke F M Ariëns; Kirsten J M van Nimwegen; Marjan Shams; Digna T de Bruin; Jorien van der Schaft; Harmieke van Os-Medendorp; Marjolein De Bruin-Weller
Journal:  Acta Derm Venereol       Date:  2019-07-01       Impact factor: 4.437

6.  Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study.

Authors:  M-A Richard; F Corgibet; M Beylot-Barry; A Barbaud; C Bodemer; V Chaussade; M D'Incan; P Joly; M T Leccia; J M Meurant; A Petit; B Roy Geffroy; J F Sei; C Taieb; L Misery; K Ezzedine
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-07-16       Impact factor: 6.166

Review 7.  Atopic dermatitis.

Authors:  Sinéad M Langan; Alan D Irvine; Stephan Weidinger
Journal:  Lancet       Date:  2020-08-01       Impact factor: 79.321

8.  Sleep Disturbance in Patients with Urticaria and Atopic Dermatitis: An Underestimated Burden.

Authors:  Caroline Mann; Matthias Dreher; Hans-Günter Weeß; Petra Staubach
Journal:  Acta Derm Venereol       Date:  2020-03-12       Impact factor: 3.875

9.  Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods.

Authors:  C R Charman; A J Venn; J C Ravenscroft; H C Williams
Journal:  Br J Dermatol       Date:  2013-12       Impact factor: 9.302

10.  Prevalence and Incidence of Atopic Dermatitis: A Systematic Review.

Authors:  Simon Bylund; Laura B Kobyletzki; Marika Svalstedt; Åke Svensson
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.